07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

GDU<br />

89301<br />

GDT<br />

89302<br />

Johannessen SI, Tomson T: Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring<br />

needed? Clin Pharmacokinetics 2006;45(11):1061-1075<br />

Gadolinium, 24 Hour, Urine<br />

Clinical Information: Gadolinium is a member of the lanthanide series of the periodic table of<br />

elements and is considered a nonessential element. Due to its paramagnetic properties, chelated<br />

gadolinium is commonly employed as contrast media for magnetic resonance imaging and computer<br />

tomography scanning. Gadolinium is eliminated primarily by the renal filtration. In healthy subjects with<br />

normal renal function, the plasma half-life of gadolinium is approximately 90 minutes. Patients with<br />

reduced renal function exhibit an increased gadolinium excretion half-life. Gadolinium has been<br />

associated with nephrogenic systemic fibrosis in patients with impaired renal function. In this syndrome,<br />

prolonged retention of gadolinium is thought to allow the gadolinium cation to dissociate from its<br />

synthetic organic chelator and deposit predominantly in the skin, although other organs may be affected as<br />

well. These patients are often severely debilitated by progressive skin thickening and tightening. Fibrosis<br />

of skeletal muscle, lungs, liver, testes, and myocardium have also been observed, often with fatal results.<br />

Because the ionic radius of gadolinium (3+) is similar to that of calcium (2+), it may also deposit in bone.<br />

Three hemodialysis treatments are required to substantially remove gadolinium from patents with<br />

impaired renal function; peritoneal dialysis is not effective.<br />

Useful For: As an aid in the diagnosis of nephrogenic systemic fibrosis<br />

Interpretation: Elevated gadolinium (>0.5 mcg/specimen) observed in a 24-hour urine specimen<br />

collected >48 hours after administration of gadolinium-containing contrast media indicates impaired<br />

ability to eliminate gadolinium. These patients have an increased risk of developing nephrogenic systemic<br />

fibrosis (NSF). Elevated gadolinium in a specimen collected

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!